Terms: = Liver cancer AND TOP1, RP3-511B24_2, 7150, ENSG00000198900, TOPI, P11387 AND Staging
2338 results:
1. Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.
Ni Q; Jia H; Zhang Y; Lu J; Chang H
Cancer Med; 2024 May; 13(10):e6952. PubMed ID: 38752672
[TBL] [Abstract] [Full Text] [Related]
2. The Usefulness of Vitamin K-Dependent Proteins in the Diagnosis of Colorectal Carcinoma.
Perné MG; Sitar-Tăut AV; Orășan OH; Negrean V; Vlad CV; Alexescu TG; Milaciu MV; Ciumărnean L; Togănel RD; Petre GE; Șimon I; Crăciun A
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732222
[TBL] [Abstract] [Full Text] [Related]
3. DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study.
Zhang B; Xue J; Xu B; Chang J; Li X; Huang Z; Zhao H; Cai J
Sci Rep; 2024 May; 14(1):10726. PubMed ID: 38730095
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
Bedair HM; El-Banna EA; Ahmed EA; Elhelbawy MG; Abdelfattah A; Khalaf FA; Abdel-Samiee M; El Sharnoby A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1411-1417. PubMed ID: 38680002
[TBL] [Abstract] [Full Text] [Related]
5. Incidentally found parotid gland lesion in
Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M
BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868
[TBL] [Abstract] [Full Text] [Related]
6. [Construction and Validation of Prediction Models of Risk Factors for Early Death in Patients With Metastatic Melanoma].
Li S; Li J; Yang Q; Yin C; Liu B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):367-374. PubMed ID: 38645854
[TBL] [Abstract] [Full Text] [Related]
7. Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study.
Lee JW; Ahn H; Yoo ID; Hong SP; Baek MJ; Kang DH; Lee SM
Cancer Imaging; 2024 Apr; 24(1):53. PubMed ID: 38627864
[TBL] [Abstract] [Full Text] [Related]
8. [Study on mechanism of icariin-induced ferroptosis in HepG2 hepatoma carcinoma cells through PPARG/FABP4/GPX4 pathway].
Li L; Zeng PH; Yang RY; Deng Y; He ZM; Xia X; Zhu DY; Peng QH
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1295-1309. PubMed ID: 38621977
[TBL] [Abstract] [Full Text] [Related]
9. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system.
Zhang J; Yimamu M; Cheng Z; Ji J; Wu L; Feng J; Xu X; Wu J; Guo C
Free Radic Biol Med; 2024 Jul; 219():31-48. PubMed ID: 38614226
[TBL] [Abstract] [Full Text] [Related]
10. Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Ohama H; Hiraoka A; Tada T; Hirooka M; Kariyama K; Hatanaka T; Tani J; Takaguchi K; Atsukawa M; Itobayashi E; Nishimura T; Tsuji K; Tajiri K; Ishikawa T; Yasuda S; Toyoda H; Fukunishi S; Ogawa C; Kakizaki S; Shimada N; Naganuma A; Kawata K; Kosaka H; Kuroda H; Matono T; Yata Y; Ochi H; Tada F; Nouso K; Morishita A; Itokawa N; Okubo T; Arai T; Tsutsui A; Nagano T; Yokohama K; Nishikawa H; Imai M; Koizumi Y; Nakamura S; Iijima H; Kaibori M; Hiasa Y; Kumada T;
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2042. PubMed ID: 38577725
[TBL] [Abstract] [Full Text] [Related]
11. Application of dynamic contrast enhanced ultrasound analysis in predicting early response to systemic therapy of intrahepatic cholangiocarcinoma.
Lu XY; Jiang J; Chen S; Qiu YJ; Wang Y; Cheng J; Xu XL; Dong Y; Wang WP
Eur J Radiol; 2024 Jun; 175():111439. PubMed ID: 38547743
[TBL] [Abstract] [Full Text] [Related]
12. Development and validation of nomograms to evaluate the survival outcome of HCC patients undergoing selective postoperative adjuvant TACE.
He Y; Qian J; Zhu G; Wu Z; Cui L; Tu S; Luo L; Shan R; Liu L; Shen W; Li Y; He K
Radiol Med; 2024 Apr; 129(4):653-664. PubMed ID: 38512609
[TBL] [Abstract] [Full Text] [Related]
13. [A Case of Conversion Surgery for Stage Ⅳ ATP-Producing Gastric cancer with Distant Metastasis].
Egami Y; Sugimura K; Katsuyama S; Masuzawa T; Yanagisawa K; Kinoshita M; Ikeshima R; Shinke G; Hiraki M; Ohmura Y; Hata T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):329-331. PubMed ID: 38494821
[TBL] [Abstract] [Full Text] [Related]
14.
Sahin E; Kus T; Aytekin A; Uzun E; Elboga U; Yilmaz L; Cayirli YB; Okuyan M; Cimen V; Cimen U
J Nucl Med; 2024 Apr; 65(4):512-519. PubMed ID: 38485276
[TBL] [Abstract] [Full Text] [Related]
15. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
16. HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study.
Attallah KA; Albannan MS; Farid K; Rizk SM; Fathy N
Technol Cancer Res Treat; 2024; 23():15330338241234790. PubMed ID: 38436112
[No Abstract] [Full Text] [Related]
17. [The impact of modified T3 sub-staging on the prognosis of gallbladder cancer patients].
Chen C; Zhang D; Li Q; Lei JJ; Geng ZM
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):302-308. PubMed ID: 38432671
[No Abstract] [Full Text] [Related]
18. Integrating Navigation-Assisted Ablation in the Locoregional Treatment of Hepatocellular Carcinoma.
Iwai Y; Agala CB; Gerber DA
JAMA Netw Open; 2024 Feb; 7(2):e240694. PubMed ID: 38421644
[TBL] [Abstract] [Full Text] [Related]
19. Preoperative predictors for non-resectability in perihilar cholangiocarcinoma.
Otto CC; Mantas A; Heij LR; Heise D; Dewulf M; Lang SA; Ulmer TF; Dahl E; Bruners P; Neumann UP; Bednarsch J
World J Surg Oncol; 2024 Feb; 22(1):48. PubMed ID: 38326854
[TBL] [Abstract] [Full Text] [Related]
20. Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study.
Wang Y; Sun X; Chen C; Ge H; Sun J; Li E; Cai Z; Fu Q; Sun X; Wu J; Ye M; Cao W; Chen Q; Wei X; Han X; Sun K; Yan Q; Huang W; Wu L; Zeng Y; Zhang Q; Liang T
Cancer Lett; 2024 Mar; 585():216654. PubMed ID: 38272344
[TBL] [Abstract] [Full Text] [Related]
[Next]
